IL1B and diabetes mellitus: All treated groups (DM, DM + A, DM + cART, and DM + A + cART) showed significant increases in IL-1β expression in comparison with the control group (p < 0.0001, p < 0.0001, p = 0.0389, and p = 0.0095 respectively).